These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17888135)

  • 1. Time and cost involved in the care of newly registered patients with diabetes mellitus and other lifestyle diseases at diabetes clinics in Japan (JDDM 4).
    Oishi M; Yokoyama H; Abe N; Iwasaki K; Okuguchi F; Kawai K; Sugimoto H; Takamura H; Takeda H; Doi K; Hirao K; Ikeda S
    Diabet Med; 2007 Oct; 24(10):1149-55. PubMed ID: 17888135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial.
    Trento M; Passera P; Bajardi M; Tomalino M; Grassi G; Borgo E; Donnola C; Cavallo F; Bondonio P; Porta M
    Diabetologia; 2002 Sep; 45(9):1231-9. PubMed ID: 12242455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE study.
    Liebl A; Breitscheidel L; Nicolay C; Happich M
    Curr Med Res Opin; 2008 Aug; 24(8):2349-58. PubMed ID: 18606055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A cost of illness study of diabetes mellitus].
    von Ferber L; Köster I; Hauner H
    Gesundheitswesen; 1997 Jan; 59(1):17-22. PubMed ID: 9138642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
    Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT
    Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-monitoring in Type 2 diabetes: a randomized trial of reimbursement policy.
    Johnson JA; Majumdar SR; Bowker SL; Toth EL; Edwards A
    Diabet Med; 2006 Nov; 23(11):1247-51. PubMed ID: 17054603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes in Japan: a review of disease burden and approaches to treatment.
    Neville SE; Boye KS; Montgomery WS; Iwamoto K; Okamura M; Hayes RP
    Diabetes Metab Res Rev; 2009 Nov; 25(8):705-16. PubMed ID: 19795421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous drug abuse and Type 1 diabetes: financial and healthcare implications.
    Saunders SA; Democratis J; Martin J; Macfarlane IA
    Diabet Med; 2004 Dec; 21(12):1269-73. PubMed ID: 15569127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of a structured intensive diabetes education programme (SIDEP) in patients with Type 2 diabetes mellitus--a 4-year follow-up study.
    Ko SH; Song KH; Kim SR; Lee JM; Kim JS; Shin JH; Cho YK; Park YM; Jeong JH; Yoon KH; Cha BY; Son HY; Ahn YB
    Diabet Med; 2007 Jan; 24(1):55-62. PubMed ID: 17227325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-care practices of Malaysian adults with diabetes and sub-optimal glycaemic control.
    Tan MY; Magarey J
    Patient Educ Couns; 2008 Aug; 72(2):252-67. PubMed ID: 18467068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China.
    Palmer JL; Gibbs M; Scheijbeler HW; Kotchie RW; Nielsen S; White J; Valentine WJ
    Adv Ther; 2008 Aug; 25(8):752-74. PubMed ID: 18704282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Structured treatment of diabetes in the country].
    Ecker J; Witzmann G; Gmeiner H; Aigner I; Said H
    Wien Med Wochenschr; 2005 Aug; 155(15-16):371-5. PubMed ID: 16160925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct cost of ambulatory care of type 2 diabetes in the middle and high income group populace of Delhi: the DEDICOM survey.
    Kumar A; Nagpal J; Bhartia A
    J Assoc Physicians India; 2008 Sep; 56():667-74. PubMed ID: 19086352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A disease management programme for patients with diabetes mellitus is associated with improved quality of care within existing budgets.
    Steuten LM; Vrijhoef HJ; Landewé-Cleuren S; Schaper N; Van Merode GG; Spreeuwenberg C
    Diabet Med; 2007 Oct; 24(10):1112-20. PubMed ID: 17672862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001.
    Lecomte P; Romon I; Fosse S; Simon D; Fagot-Campagna A
    Diabetes Metab; 2008 Jun; 34(3):219-26. PubMed ID: 18343703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the Diabetes Manual 1:1 structured education in primary care.
    Sturt JA; Whitlock S; Fox C; Hearnshaw H; Farmer AJ; Wakelin M; Eldridge S; Griffiths F; Dale J
    Diabet Med; 2008 Jun; 25(6):722-31. PubMed ID: 18435777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of medical care among type 2 diabetic patients with a co-morbid condition--hypertension in India.
    Tharkar S; Satyavani K; Viswanathan V
    Diabetes Res Clin Pract; 2009 Feb; 83(2):263-7. PubMed ID: 19118912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.